PLX PHARMA INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

On January 19, 2023, John W. Hadden II, a member of the Board of Directors (the "Board") of PLx Pharma, Inc. (the "Company"), resigned from the Board effective immediately. Mr. Hadden's resignation is not the result of any disagreement with the Company.

 Item 8.01 Other Events.

In August 2022, and as previously disclosed, the Company engaged Raymond James & Associates, Inc. as financial advisor to evaluate strategic alternatives to maximize stockholder value. On January 14, 2023, the Company engaged SierraConstellation Partners LLC, a business advisory firm, to further explore strategic alternatives, which may include a liquidation strategy in the event that more advantageous alternatives prove unavailable to the Company.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits



  Exhibit No. Description

  104         Cover Page Interactive Data File (the cover page XBRL tags are
              embedded within the Inline XBRL document).

© Edgar Online, source Glimpses